SAVIENT PHARMACEUTICALS INC
SVNT
SVNT was delisted on the 16th of October, 2013.
2 hedge funds and large institutions have $0 invested in SAVIENT PHARMACEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.
71% less funds holding
Funds holding: 7 → 2 (-5)
100% less capital invested
Capital invested by funds: $5K → $0 (-$5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$2K |
| 2 |
FHC
First Heartland Consultants
Lake St. Louis,
Missouri
|
-$1K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Group One Trading
Chicago,
Illinois
| – | -$2K | -138,460 | Closed |
|
|
FHC
2
First Heartland Consultants
Lake St. Louis,
Missouri
| – | -$1K | -45,453 | Closed |
|
|
WS
3
Wedbush Securities
Los Angeles,
California
| – | -$1K | -30,767 | Closed |
|
SVNT Hedge Fund Activity: Q1 2014 in Review
2 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q1 2014, worth a combined $0 — down 100% from $5K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SVNT and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Group One Trading, exiting entirely with an estimated $2K sold.
- 2 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q1 2014, down from 7 in Q4 2013.
- Funds reported $0 of SAVIENT PHARMACEUTICALS INC stock for Q1 2014, down 100% quarter-over-quarter.
- 0 funds opened new SAVIENT PHARMACEUTICALS INC positions in Q1 2014 and 5 closed out, a net change of -5 holders.
- The largest SAVIENT PHARMACEUTICALS INC seller in Q1 2014 was Group One Trading, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2014.